Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial

Gerd Fastner¹, Roland Reitsamer², Felix Sedlmayer³

Affiliations

¹ Department of Radiotherapy and Radio-Oncology, Paracelsus Medical University, University Hospital Salzburg, Landeskrankenhaus, Salzburg 5020, Austria. Electronic address: g.fastner@salk.at.
² Department of Gynecology, Paracelsus Medical University, University Hospital Salzburg, Landeskrankenhaus, Salzburg, Austria.
³ Department of Radiotherapy and Radio-Oncology, Paracelsus Medical University, University Hospital Salzburg, Landeskrankenhaus, Salzburg 5020, Austria.

PMID: 34197754
DOI: 10.1016/S1470-2045(21)00257-6

Comment

Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial

Gerd Fastner et al. Lancet Oncol. 2021 Jul.

. 2021 Jul;22(7):e293.

doi: 10.1016/S1470-2045(21)00257-6.

Authors

Gerd Fastner¹, Roland Reitsamer², Felix Sedlmayer³

Affiliations

¹ Department of Radiotherapy and Radio-Oncology, Paracelsus Medical University, University Hospital Salzburg, Landeskrankenhaus, Salzburg 5020, Austria. Electronic address: g.fastner@salk.at.
² Department of Gynecology, Paracelsus Medical University, University Hospital Salzburg, Landeskrankenhaus, Salzburg, Austria.
³ Department of Radiotherapy and Radio-Oncology, Paracelsus Medical University, University Hospital Salzburg, Landeskrankenhaus, Salzburg 5020, Austria.

PMID: 34197754
DOI: 10.1016/S1470-2045(21)00257-6

No abstract available

PubMed Disclaimer

Conflict of interest statement

GF declares lecture honoraria from Roche. FS declares research grants from IntraOp Medical and Cancer Aid Salzburg, and lecture honoraria from Janssen, Bristol Myers Squibb, and Astellas. RR declares no competing interests.

Comment in

Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial - Authors' reply.
Orecchia R, Maisonneuve P, Leonardi MC. Orecchia R, et al. Lancet Oncol. 2021 Jul;22(7):e298. doi: 10.1016/S1470-2045(21)00355-7. Lancet Oncol. 2021. PMID: 34197758 No abstract available.

Comment on

Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial.
Orecchia R, Veronesi U, Maisonneuve P, Galimberti VE, Lazzari R, Veronesi P, Jereczek-Fossa BA, Cattani F, Sangalli C, Luini A, Caldarella P, Venturino M, Sances D, Zurrida S, Viale G, Leonardi MC, Intra M. Orecchia R, et al. Lancet Oncol. 2021 May;22(5):597-608. doi: 10.1016/S1470-2045(21)00080-2. Epub 2021 Apr 9. Lancet Oncol. 2021. PMID: 33845035 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial

Affiliations

Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial

Authors

Affiliations

Conflict of interest statement

Comment in

Comment on

Publication types

MeSH terms